TABLE 2.
General clinical characteristics of different metastatic sites in bone-metastatic LADC patients.
| All patients | Bone metastasis site | |||||||
|---|---|---|---|---|---|---|---|---|
| Clavicle or scapula | Sternum | Skull | Humerus | Femur | Pelvis | Rib | Spine | |
| Total a | 10 | 10 | 13 | 17 | 22 | 36 | 60 | 103 |
| Age (years) | ||||||||
| <65 | 6 (60.0%) | 7 (70.0%) | 5 (38.5%) | 13 (76.5%) | 16 (72.7%) | 21 (58.3%) | 36 (60.0%) | 58 (56.3%) |
| ≥65 | 4 (40.0%) | 3 (30.0%) | 8 (61.5%) | 4 (23.5%) | 6 (27.3%) | 15 (41.7%) | 24 (40.0%) | 45 (43.7%) |
| Gender | ||||||||
| Male | 9 (90.0%) | 6 (60.0%) | 4 (30.8%) | 12 (70.6%) | 10 (45.5%) | 17 (47.2%) | 39 (65.0%) | 52 (50.5%) |
| Female | 1 (10.0%) | 4 (40.0%) | 9 (69.2%) | 5 (29.4%) | 12 (54.5%) | 19 (52.8%) | 21 (35.0%) | 51 (49.5%) |
| Smoking history | ||||||||
| Never smoker | 2 (20.0%) | 2 (20.0%) | 3 (23.1%) | 1 (5.9%) | 3 (13.6%) | 4 (11.1%) | 5 (8.3%) | 15 (14.6%) |
| Ex-smoker | 1 (10.0%) | 3 (30.0%) | 3 (23.1%) | 3 (17.6%) | 4 (18.2%) | 11 (30.6%) | 17 (28.3%) | 21 (20.4%) |
| Current smoker | 3 (30.0%) | 0 (0.0%) | 2 (15.4%) | 7 (41.2%) | 7 (31.8%) | 10 (27.8%) | 20 (33.3%) | 30 (29.1%) |
| N/A | 4 (40.0%) | 5 (50.0%) | 5 (38.5%) | 6 (35.3%) | 8 (36.4%) | 11 (30.6%) | 18 (30.0%) | 37 (35.9%) |
a
The final number of included patients is 209. However, as a single patient does not necessarily present metastasis in specifically one bone, the overall number of metastases might be higher.